Butyrylcholinesterase K and Apolipoprotein epsilon 4 Affect Cortical Thickness and Neuropsychiatric Symptoms in Alzheimer's Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Hye B. | - |
dc.contributor.author | Lee, Hae W. | - |
dc.contributor.author | Shin, Sue | - |
dc.contributor.author | Park, Sun-Won | - |
dc.contributor.author | Choi, Jung S. | - |
dc.contributor.author | Jung, Hee Y. | - |
dc.contributor.author | Cha, Jungho | - |
dc.contributor.author | Lee, Jong-Min | - |
dc.contributor.author | Lee, Jun-Young | - |
dc.date.accessioned | 2022-07-16T06:09:21Z | - |
dc.date.available | 2022-07-16T06:09:21Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2014-02 | - |
dc.identifier.issn | 1567-2050 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/160724 | - |
dc.description.abstract | Two major genotypes are known to affect the development and progression of Alzheimer's disease (AD) and its response to cholinesterase inhibitors: the apolipoprotein E (ApoE) and butyrylcholinesterase genes (BChE). This study analyzed the effects of the BChE and ApoE genotypes on the cortical thickness of patients with AD and examined how these genotypes affect the neuropsychiatric symptoms of AD. AD-drug-naive patients who met the probable AD criteria proposed by the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association were recruited. Of 96 patients with AD, 65 were eligible for cortical thickness analysis. 3D T1-weighted images were acquired, and the cortical regions were segmented using the constrained Laplacian-based automated segmentation with proximities (CLASP) algorithm. Neuropsychiatric symptoms were measured by Neuropsychiatric Inventory (NPI) scores. BChE wild-type carriers (BChE-W) showed more thinning in the left dorsolateral prefrontal cortex, including the lateral premotor regions and anterior cingulate cortex, than did BChE-K variant carriers (BChE-K). ApoE-epsilon 4 carriers had a thinner left medial prefrontal cortex, left superior frontal cortex, and left posterior cingulate cortex than did ApoE-epsilon 4 non-carriers. Statistical analyses revealed that BChE-K carriers showed significantly less severe aberrant motor behavioral symptoms and that epsilon 4 non-carriers showed less severe anxiety and indifference symptoms. The current findings show that, similar to ApoE-epsilon 4 non-carriers, BChE-K carriers are protected from the pathological detriments of AD that affect frontal cortical thickness and neuropsychiatric symptoms. This study visually demonstrated the effects of the BChE-K and ApoE genotypes on the structural degeneration and complex aspects of the symptoms of AD. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BENTHAM SCIENCE PUBL LTD | - |
dc.title | Butyrylcholinesterase K and Apolipoprotein epsilon 4 Affect Cortical Thickness and Neuropsychiatric Symptoms in Alzheimer's Disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Jong-Min | - |
dc.identifier.doi | 10.2174/1567205011666140130152114 | - |
dc.identifier.scopusid | 2-s2.0-84897426110 | - |
dc.identifier.wosid | 000333195900005 | - |
dc.identifier.bibliographicCitation | CURRENT ALZHEIMER RESEARCH, v.11, no.2, pp.137 - 144 | - |
dc.relation.isPartOf | CURRENT ALZHEIMER RESEARCH | - |
dc.citation.title | CURRENT ALZHEIMER RESEARCH | - |
dc.citation.volume | 11 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 137 | - |
dc.citation.endPage | 144 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | AUTOMATED 3-D EXTRACTION | - |
dc.subject.keywordPlus | KOREAN VERSION | - |
dc.subject.keywordPlus | APOE GENOTYPE | - |
dc.subject.keywordPlus | DEMENTIA | - |
dc.subject.keywordPlus | ALLELE | - |
dc.subject.keywordPlus | DONEPEZIL | - |
dc.subject.keywordPlus | RIVASTIGMINE | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | DECLINE | - |
dc.subject.keywordPlus | MRI | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | apolipoprotein epsilon 4 | - |
dc.subject.keywordAuthor | behavior | - |
dc.subject.keywordAuthor | butyrylcholinesterase | - |
dc.subject.keywordAuthor | cerebral cortex | - |
dc.subject.keywordAuthor | genetics | - |
dc.identifier.url | http://www.eurekaselect.com/article/58908 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.